| 221.19 Data as of Jun 06 |  +7.09 / +3.31%Today’s Change | 132.01 Today|||52-Week Range 242.64 | +51.12% Year-to-Date |
| Encouraging Data on Isis Candidate - Analyst Blog Jun 06 / Zacks.com | Biogen Idec Inc (BIIB): Today's Featured Health Care Laggard Jun 03 / TheStreet.com |
| 'Mad Money' Lightning Round: Amgen's Not a Fave Jun 06 / TheStreet.com | CHMP Positive on Teva's Lonquex - Analyst Blog Jun 03 / Zacks.com |
| Cramer's 'Mad Money' Recap: Profit While You Can Jun 05 / TheStreet.com | FDA Accepts Teva sNDA - Analyst Blog May 31 / Zacks.com |
| The Medicines Co. Inks Deal with ProFibrix - Analyst Blog Jun 05 / Zacks.com | Biogen Delays EU Launch of Tecfidera - Analyst Blog May 31 / Zacks.com |
| Canada Nod for Medivation's Xtandi - Analyst Blog Jun 04 / Zacks.com | Elan / Royalty Pharma: number crunchers May 30 / FT.com |
| Previous close | 214.10 |
| Today’s open | 214.35 |
| Day’s range | -- - -- |
| Volume | 1,612,129 |
| Average volume (3 months) | 1,442,459 |
| Market cap | $50.8B |
| Dividend yield | -- |
| Earnings growth (last year) | +14.29% |
| Earnings growth (this year) | +23.87% |
| Earnings growth (next 5 years) | +18.50% |
| Revenue growth (last year) | +7.78% |
| P/E ratio | 35.1 |
| Price/Sales | 6.35 |
| Price/Book | 7.28 |
| Today’s change | Today’s % change | |
|---|---|---|
| BAXBaxter International... | +0.69 | +1.00% |
| AMGNAmgen Inc | +2.89 | +3.05% |
| GILDGilead Sciences Inc | +1.23 | +2.45% |
| LIFELife Technologies Co... | +0.23 | +0.31% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $1.90 |
| Annual revenue (last year) | $5.5B |
| Annual profit (last year) | $1.4B |
| Net profit margin | 25.18% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director George A. Scangos, PhD |
Chief Financial Officer & Executive Vice President Paul J. Clancy, MBA |
Corporate headquarters Weston, Massachusetts |
.
